Loss of SPARC in Bladder Cancer Enhances Carcinogenesis and Progression

Journal of Clinical Investigation - United States
doi 10.1172/jci71241
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

American Society for Clinical Investigation

Related search

Roles of SPARC in Urothelial Carcinogenesis, Progression and Metastasis

Oncotarget
Oncology
2016English

Loss of BCAA Catabolism During Carcinogenesis Enhances mTORC1 Activity and Promotes Tumor Development and Progression

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2019English

Loss of 15-Hydroxyprostaglandin Dehydrogenase Expression Contributes to Bladder Cancer Progression

American Journal of Pathology
Forensic MedicinePathology
2010English

Loss of P63 Expression Is Associated With Tumor Progression in Bladder Cancer

American Journal of Pathology
Forensic MedicinePathology
2002English

LINC00319-Mediated miR-3127 Repression Enhances Bladder Cancer Progression Through Upregulation of RAP2A

Frontiers in Genetics
GeneticsMolecular Medicine
2020English

The Expression of Presenilin 1 Enhances Carcinogenesis and Metastasis in Gastric Cancer

Oncotarget
Oncology
2016English

Loss of GAS5 Tumour Suppressor lncRNA: An Independent Molecular Cancer Biomarker for Short-Term Relapse and Progression in Bladder Cancer Patients

British Journal of Cancer
Cancer ResearchOncology
2018English

PLXNC1 Enhances Carcinogenesis Through Transcriptional Activation of IL6ST in Gastric Cancer

Frontiers in Oncology
Cancer ResearchOncology
2020English

BMI1 and Mel-18 Oppositely Regulate Carcinogenesis and Progression of Gastric Cancer

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy